The FDA approved Hepcludex (bulevirtide-gmod), the first treatment for chronic hepatitis delta virus (HDV) in adults with or without compensated cirrhosis. Clinical trials showed significantly higher...
Researchers discovered a vulnerability in the hepatitis B virus (HBV) that could lead to new treatments. They found that CBL137, a cancer drug, blocks the virus’s...